Editorial : a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis? Author's reply
Errataetall: |
CommentOn: Aliment Pharmacol Ther. 2020 Jun;51(11):1139-1148. - PMID 32301137 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Alimentary pharmacology & therapeutics - 52(2020), 3 vom: 05. Aug., Seite 546-547 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Camilleri, Michael [VerfasserIn] |
---|
Links: |
---|
Themen: |
BIW199E18V |
---|
Anmerkungen: |
Date Completed 25.08.2020 Date Revised 25.08.2020 published: Print CommentOn: Aliment Pharmacol Ther. 2020 Jun;51(11):1139-1148. - PMID 32301137 Citation Status MEDLINE |
---|
doi: |
10.1111/apt.15866 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM312335350 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM312335350 | ||
003 | DE-627 | ||
005 | 20231225144210.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/apt.15866 |2 doi | |
028 | 5 | 2 | |a pubmed24n1041.xml |
035 | |a (DE-627)NLM312335350 | ||
035 | |a (NLM)32656828 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Camilleri, Michael |e verfasserin |4 aut | |
245 | 1 | 0 | |a Editorial |b a need for glucose monitoring on prokinetic treatment with a ghrelin agonist in diabetic gastroparesis? Author's reply |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 25.08.2020 | ||
500 | |a Date Revised 25.08.2020 | ||
500 | |a published: Print | ||
500 | |a CommentOn: Aliment Pharmacol Ther. 2020 Jun;51(11):1139-1148. - PMID 32301137 | ||
500 | |a Citation Status MEDLINE | ||
650 | 4 | |a Editorial | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Comment | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Ghrelin |2 NLM | |
650 | 7 | |a Oligopeptides |2 NLM | |
650 | 7 | |a relamorelin |2 NLM | |
650 | 7 | |a BIW199E18V |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Alimentary pharmacology & therapeutics |d 1992 |g 52(2020), 3 vom: 05. Aug., Seite 546-547 |w (DE-627)NLM012692506 |x 1365-2036 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2020 |g number:3 |g day:05 |g month:08 |g pages:546-547 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/apt.15866 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2020 |e 3 |b 05 |c 08 |h 546-547 |